Data Science Funding Announcements & Notices
Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.
| Title | FOA | Organization | Release Date | Expire Date | Purpose |
|---|---|---|---|---|---|
| Targeting Inflammasomes in HIV and Substance Use (R01 Clinical Trial Not Allowed) | RFA-DA-25-069 | NIDA | The scientific objective of this Notice of Funding Opportunity is to encourage research to delineate the role of inflammasomes in the neuropathology produced by acute or chronic drug exposure and HIV… More | ||
| Advancing Research on Molecular Targets and Mechanisms that Influence the Interplay Between Sex Hormones, HIV, and Addictive Substances (R01 Clinical Trials Not Allowed) | RFA-DA-26-007 | NIDA | The purpose of this notice of funding opportunity (NOFO) is to support studies to delineate the mechanisms by which sex hormones influence the consequences of comorbid HIV and drug use and use this… More | ||
| Targeting Inflammasomes in HIV and Substance Use (R21 Clinical Trial Not Allowed) | RFA-DA-25-068 | NIDA | The scientific objective of this Notice of Funding Opportunity is to encourage research to delineate the role of inflammasomes in the neuropathology produced by acute or chronic drug exposure and HIV… More | ||
| Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial required) | RFA-DA-25-072 | NIDA | The purpose of this NOFO is to support the testing of enhanced models of care that optimally integrate HIV, addiction, and primary care services. | ||
| Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial Optional) | RFA-DA-25-070 | NIDA | The purpose of this NOFO is to support the testing of enhanced models of care that optimally integrate HIV, addiction, and primary care services. | ||
| Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial optional) | RFA-DA-25-020 | NIDA | The purpose of this FOA is to support the testing of enhanced models of care that optimally integrate HIV, addiction, and primary care services. | ||
| Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional) | PAR-24-299 | NIDA | The purpose of this funding opportunity announcement (FOA) is to encourage behavioral intervention development research to test efficacy, conduct clinical trials, examine mechanisms of behavior… More | ||
| Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional) | PAR-24-300 | NIDA | The purpose of this funding opportunity announcement (FOA) is to encourage behavioral intervention development research to test efficacy, conduct clinical trials, examine mechanisms of behavior… More | ||
| Functional Validation and/or Characterization of Genes or Variants Implicated in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed) | PAR-24-267 | NIDA | The purpose of this initiative is to support projects which exploit genome or epigenome editing to functionally validate and characterize genes or variants involved in substance use disorder-relevant… More | ||
| Ex Vivo Models for Studies at the Intersection of HIV and Poly-Substance Use (R01 Clinical Trial Not Allowed) | RFA-DA-24-001 | NIDA | This Funding Opportunity Announcement (FOA) invites grant applications aimed at elucidating neuroimmune and neuronal-glial pathophysiological mechanisms of HIV-associated neurological disorders (HAND… More |